Jpmorgan Chase & CO Quoin Pharmaceuticals, Ltd. Transaction History

Jpmorgan Chase & CO

  • $1.22 Trillion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 11, 2022
SELL
$13.25 - $26.75 $1,643 - $3,317
-124 Closed
0 $0
Q4 2021

Feb 10, 2022
BUY
$22.38 - $232.38 $2,775 - $28,815
124 New
124 $0

About Quoin Pharmaceuticals, Ltd.

QNRX Quotes by TradingView
  • Ticker QNRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 4,846,600
  • Market Cap $2.81M
  • Description
  • Quoin Pharmaceuticals, Ltd., a clinical stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases. Its lead product is QRX003, a topical lotion to treat Netherton Syndrome. The company also offers three other pipeline products in development, which are also targe...
More about QNRX
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email